150 related articles for article (PubMed ID: 33351221)
1. Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in patients with newly diagnosed prostate cancer referred to androgen-deprivation therapy.
R Buskbjerg C; Zachariae R; Buus S; H Gravholt C; Haldbo-Classen L; Hosseini SMH; Amidi A
Cancer; 2021 May; 127(9):1495-1506. PubMed ID: 33351221
[TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes.
Buskbjerg CR; Amidi A; Buus S; Gravholt CH; Hadi Hosseini SM; Zachariae R
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):208-218. PubMed ID: 34088994
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients.
Buskbjerg CR; Zachariae R; Agerbæk M; Gravholt CH; Haldbo-Classen L; Hosseini SMH; Amidi A
Brain Imaging Behav; 2022 Feb; 16(1):199-210. PubMed ID: 34392471
[TBL] [Abstract][Full Text] [Related]
4. Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients-A prospective controlled study.
Buskbjerg CR; Amidi A; Agerbaek M; Gravholt CH; Hosseini SH; Zachariae R
Cancer Med; 2021 Sep; 10(18):6249-6260. PubMed ID: 34390226
[TBL] [Abstract][Full Text] [Related]
5. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
Li W; Zhao J; Ding K; Chao HH; Li CR; Cheng H; Shen L
Med Sci Monit; 2020 Sep; 26():e923567. PubMed ID: 32985495
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy increases brain ageing.
Plata-Bello J; Plata-Bello A; Pérez-Martín Y; Fajardo V; Concepción-Massip T
Aging (Albany NY); 2019 Aug; 11(15):5613-5627. PubMed ID: 31377745
[TBL] [Abstract][Full Text] [Related]
8. Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.
Sapkota S; Bäckman L; Dixon RA
Neurobiol Aging; 2017 Apr; 52():81-89. PubMed ID: 28131014
[TBL] [Abstract][Full Text] [Related]
9. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis.
Chao HH; Uchio E; Zhang S; Hu S; Bednarski SR; Luo X; Rose M; Concato J; Li CS
BMC Cancer; 2012 Aug; 12():371. PubMed ID: 22925152
[TBL] [Abstract][Full Text] [Related]
10. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Gonzalez BD; Jim HS; Booth-Jones M; Small BJ; Sutton SK; Lin HY; Park JY; Spiess PE; Fishman MN; Jacobsen PB
J Clin Oncol; 2015 Jun; 33(18):2021-7. PubMed ID: 25964245
[TBL] [Abstract][Full Text] [Related]
11. Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition.
Izard JP; Siemens DR
Eur Urol Focus; 2020 Nov; 6(6):1162-1164. PubMed ID: 31911085
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
13. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer, Use of Androgen Deprivation Therapy, and Cognitive Impairment: A Population-based Study.
Alonso Quiñones HJ; Stish BJ; Hagen C; Petersen RC; Mielke MM
Alzheimer Dis Assoc Disord; 2020; 34(2):118-121. PubMed ID: 31821185
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment among prostate cancer patients: An overview of reviews.
Treanor CJ; Li J; Donnelly M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28169490
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).
Rosa RF; Ugolini-Lopes MR; Gandara APR; Vendramini MBG; Campanholo KR; Dutra L; de Andrade DCO
Rheumatology (Oxford); 2021 Jan; 60(1):179-187. PubMed ID: 32613245
[TBL] [Abstract][Full Text] [Related]
18. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
Sapkota S; Dixon RA
J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
Sun M; Cole AP; Hanna N; Mucci LA; Berry DL; Basaria S; Ahern DK; Kibel AS; Choueiri TK; Trinh QD
J Urol; 2018 Jun; 199(6):1417-1425. PubMed ID: 29410294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
